New multidisciplinary projects across the country will prepare Canada for future health emergencies and build capacity

MONTRÉAL, May 6, 2024 /CNW/ - Growing a robust, competitive, domestic biomanufacturing and life sciences sector ensures that Canada has access to critical vaccines, therapeutics and other life-saving medicines. The Government of Canada has been doing just that since the launch of Canada's Biomanufacturing and Life Sciences Strategy in 2021 with a $2.2 billion commitment to develop cutting-edge biomanufacturing capabilities.